Which medications in the drug class Thrombolytics are used in the treatment of Superior Vena Cava Syndrome?

Updated: Mar 26, 2018
  • Author: Todd A Nickloes, DO, FACOS; Chief Editor: Vincent Lopez Rowe, MD  more...
  • Print


The potential benefits of thrombolytics for the treatment of pulmonary embolism include fast dissolution of physiologically compromising pulmonary emboli, quickened recovery, prevention of recurrent thrombus formation, and rapid restoration of hemodynamic disturbances. For deep vein thrombosis, lysis of the thrombus can prevent pulmonary embolism and permanent pathologic changes, such as venous valvular dysfunction and postphlebitic syndrome.

Urokinase (Abbokinase)

Converts plasminogen to plasmin, which degrades fibrin clots, fibrinogen, and other plasma proteins.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!